|
Metacognitive Therapy Compared to Cognitive-behavioral Therapy
RECRUITINGN/ASponsored by Karolinska Institutet
Actively Recruiting
PhaseN/A
SponsorKarolinska Institutet
Started2026-01-28
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07382323
Summary
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Age 18 years or older, * A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder, * No change in dose during the last six weeks if on pharmacological treatment, and * Ability to read and speak Swedish. Exclusion Criteria: * A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder, * Acute suicide risk, or * Concurrent psychological treatment.
Conditions4
AnxietyGeneralized Anxiety DisorderPosttraumatic Stress Disorder (PTSD)Social Anxiety Disorder
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorKarolinska Institutet
Started2026-01-28
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07382323